EVITA TEST COMPLETE
Commercial- Indications
- Prenatal genetic testing
Company intelligence / Profile preview
The company offers "EVITA TEST COMPLETE," which provides genome-wide non-invasive prenatal testing by analyzing circulating fetal cells. This test is unique in offering comprehensive chromosomal analysis without invasive procedures like amniocentesis or CVS. Clinical studies include biomarker research for preterm birth using isolated amniochorionic membrane cells[1][4][8].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ARCEDI Biotech.